12-Month Lobbying Summary - Organization

Novo Nordisk Canada Inc. / Vince Lamanna, President

Registration Summary

Currently active - Last Updated: 2023-12-01

Who is lobbying?

Novo Nordisk Canada Inc. (Address & business activities)

Vince Lamanna, President

Senior Officer in previous versions
- Beatrice Clerc, President

Government Funding

Did Novo Nordisk Canada Inc. request or receive government funding within the last 12 months? No

Coalition Members Information

Novo Nordisk Canada Inc. is not a coalition member.

Direct Interests of the Lobbying Activity

Affiliates

Novo Nordisk Canada Inc. has the following affiliates that could have a direct interest in the outcome of the lobbying activities:

Novo Nordisk A/S (Parent Company) (Address information)
Novo Nordisk North America Operations A/S (Shareholder) (Address information)

Other Affiliates

The activities of Novo Nordisk Canada Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking

Contributors with a Direct Interest in the Outcome

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of Novo Nordisk Canada Inc.:

What is being lobbied?

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Advocacy regarding policies/issues of public health as it relates to diabetes/obesity management and prevention.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Children and Families, Education, Government Procurement, Health, Hospitals
Policy and program discussions from a broader innovative manufacturer industry perspective regarding the government's delivery of health care and/or access to appropriate/approved medications.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Finances and Budgets, Health, Hospitals
Seeking public listing and reimbursement of Novo Nordisk innovative medicines on BC formularies.	Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Government Procurement, Health, Hospitals

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Who is being lobbied?

Ministries/Provincial Entities

Finance
Fraser Health Authority
Health
Innovate BC
Interior Health Authority
Member(s) of the BC Legislative Assembly
Nisga'a Valley Health Authority
Northern Health Authority
Provincial Health Services Authority
University of British Columbia
Vancouver Coastal Health Authority
Vancouver Island Health Authority

Who are the lobbyists?

In-house Lobbyists

Lobbyist

Contributions

Martine Carbonneau
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No